Amicus Therapeutics, Inc. FOLD

Full chart Compare
Set alert

Price alert · FOLD

All alert types
14.49 USD 0.00 (+0.00%)

At closeApr 27, 2026, 4:00 PM EDT

14.49 0.00 0.00%

After hours · Apr 27, 4:00 PM ET

14.49 Day range 14.49

52-week range unavailable

YTD
+1.76%
1 year
+97.14%

Revenue & Expenses

Other Income → Expenses: $13.56MExpenses → Selling, General & Admin: $383.49MExpenses → Research & Development: $135.84MExpenses → Other Operating Expenses: $9.16MExpenses → Interest Expense: $46.16MExpenses → Income Tax: $27.30MGross Profit → Expenses: $561.28MRevenue → Gross Profit: $561.28MRevenue → Cost of Revenue: $72.93MNet Loss → Expenses: $27.11MOther Income$13.56MGross Profit$561.28MNet Loss$27.11MCost of Revenue$72.93MExpenses$601.95MSelling, General & Admin$383.49MResearch & Development$135.84MOther Operating Expenses$9.16MInterest Expense$46.16MIncome Tax$27.30MRevenue$634.21M

Latest period ending Dec 31, 2025 · select a line to chart its full history

FOLD annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
634.21M528.29M399.36M329.23M305.51M
561.28M475.35M362.03M290.63M271.05M
32.79M24.88M-74.63M-211.04M-199.92M
-27.11M-56.11M-151.58M-236.57M-250.46M
-0.09-0.18-0.51-0.82-0.92
FOLD annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
214.01M213.75M246.99M148.81M245.20M
949.87M785.03M777.88M724.17M905.14M
675.63M590.99M617.71M601.12M597.77M
442.36M443.64M445.06M452.12M440.13M
274.24M194.04M160.17M123.05M307.37M
FOLD annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
33.15M-33.89M-69.09M-166.57M-202.49M
-46.43M-560.00K98.06M92.32M78.76M
610.00K5.12M61.68M-7.46M212.07M
-3.30M-3.55M-7.44M-355.00K-3.88M
600.00K-33.36M96.96M-96.34M83.29M